PT885004E - Utilizacao de derivados de 4-fenil-3,6-di-hidro-2h-piridilo como bloqueadores dos subtipos dos receptores nmda - Google Patents
Utilizacao de derivados de 4-fenil-3,6-di-hidro-2h-piridilo como bloqueadores dos subtipos dos receptores nmdaInfo
- Publication number
- PT885004E PT885004E PT97905107T PT97905107T PT885004E PT 885004 E PT885004 E PT 885004E PT 97905107 T PT97905107 T PT 97905107T PT 97905107 T PT97905107 T PT 97905107T PT 885004 E PT885004 E PT 885004E
- Authority
- PT
- Portugal
- Prior art keywords
- nmda receptor
- blockers
- hydrogen
- dihydro
- phenyl
- Prior art date
Links
- -1 4-PHENYL-3,6-DIHYDRO-2H-PYRIDYL Chemical class 0.000 title abstract 3
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 title abstract 2
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96103636 | 1996-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT885004E true PT885004E (pt) | 2002-08-30 |
Family
ID=8222541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97905107T PT885004E (pt) | 1996-03-08 | 1997-02-27 | Utilizacao de derivados de 4-fenil-3,6-di-hidro-2h-piridilo como bloqueadores dos subtipos dos receptores nmda |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5962472A (pt) |
| EP (1) | EP0885004B1 (pt) |
| JP (1) | JP3248917B2 (pt) |
| KR (1) | KR100352358B1 (pt) |
| CN (1) | CN1131031C (pt) |
| AT (1) | ATE216883T1 (pt) |
| AU (1) | AU717140B2 (pt) |
| BR (1) | BR9708171A (pt) |
| CA (1) | CA2248134A1 (pt) |
| DE (1) | DE69712325T2 (pt) |
| DK (1) | DK0885004T3 (pt) |
| ES (1) | ES2174220T3 (pt) |
| PT (1) | PT885004E (pt) |
| TR (1) | TR199801774T2 (pt) |
| WO (1) | WO1997032581A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1674087A1 (en) | 2000-10-02 | 2006-06-28 | Pfizer Products Inc. | Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
| EP1436258A4 (en) * | 2001-03-08 | 2005-03-23 | Univ Emory | PH VALVE DEPENDENT NMDA RECEPTOR ANTAGONISTS |
| US6951875B2 (en) | 2001-10-29 | 2005-10-04 | Hoffmann-La Roche Inc. | Conjugated aromatic compounds with a pyridine substituent |
| US7005432B2 (en) * | 2002-05-16 | 2006-02-28 | Hoffman-La Roche Inc. | Substituted imidazol-pyridazine derivatives |
| WO2005051919A1 (en) * | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Aminopyrazole derivatives as gsk-3 inhibitors |
| JP2010532382A (ja) * | 2007-06-29 | 2010-10-07 | エモリー・ユニバーシテイ | 神経保護のためのｎｍｄａ受容体拮抗薬 |
| NZ588698A (en) * | 2008-03-27 | 2012-06-29 | Evotec Neurosciences Gmbh | Methods for treating disorders using nmda nr2b-subtype selective antagonist |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH543509A (de) * | 1968-12-24 | 1973-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von aromatischen Äthern |
| CH558354A (de) * | 1970-06-17 | 1975-01-31 | Hoffmann La Roche | Verfahren zur herstellung von aromatischen aethern. |
| CH547802A (de) * | 1970-06-19 | 1974-04-11 | Hoffmann La Roche | Verfahren zur herstellung von tetrahydropyridinderivaten. |
| US3879405A (en) * | 1970-06-19 | 1975-04-22 | Hoffmann La Roche | Tetrahydropyridine derivatives |
| US5149817A (en) * | 1990-03-05 | 1992-09-22 | Shionogi & Co., Ltd. | Teirahydropyridine derivatives |
| DE4325855A1 (de) * | 1993-08-02 | 1995-02-09 | Boehringer Ingelheim Kg | Neue Benzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE4325885A1 (de) * | 1993-08-02 | 1995-02-09 | Basf Ag | Elektrolumineszierende Anordnung |
| DE4410822A1 (de) * | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| US5698565A (en) * | 1995-06-09 | 1997-12-16 | Hoffmann-La Roche Inc. | Use of phenoxy-pyridine derivatives |
-
1997
- 1997-02-27 AU AU18782/97A patent/AU717140B2/en not_active Ceased
- 1997-02-27 CA CA002248134A patent/CA2248134A1/en not_active Abandoned
- 1997-02-27 JP JP53141697A patent/JP3248917B2/ja not_active Expired - Fee Related
- 1997-02-27 ES ES97905107T patent/ES2174220T3/es not_active Expired - Lifetime
- 1997-02-27 BR BR9708171A patent/BR9708171A/pt not_active Application Discontinuation
- 1997-02-27 DK DK97905107T patent/DK0885004T3/da active
- 1997-02-27 DE DE69712325T patent/DE69712325T2/de not_active Expired - Fee Related
- 1997-02-27 CN CN97192889A patent/CN1131031C/zh not_active Expired - Fee Related
- 1997-02-27 EP EP97905107A patent/EP0885004B1/en not_active Expired - Lifetime
- 1997-02-27 PT PT97905107T patent/PT885004E/pt unknown
- 1997-02-27 WO PCT/EP1997/000951 patent/WO1997032581A1/en not_active Ceased
- 1997-02-27 AT AT97905107T patent/ATE216883T1/de not_active IP Right Cessation
- 1997-02-27 KR KR10-1998-0706936A patent/KR100352358B1/ko not_active Expired - Fee Related
- 1997-02-27 TR TR1998/01774T patent/TR199801774T2/xx unknown
- 1997-03-07 US US08/813,523 patent/US5962472A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0885004A1 (en) | 1998-12-23 |
| CA2248134A1 (en) | 1997-09-12 |
| ATE216883T1 (de) | 2002-05-15 |
| CN1131031C (zh) | 2003-12-17 |
| KR19990087505A (ko) | 1999-12-27 |
| CN1213304A (zh) | 1999-04-07 |
| WO1997032581A1 (en) | 1997-09-12 |
| JP3248917B2 (ja) | 2002-01-21 |
| TR199801774T2 (xx) | 1998-12-21 |
| DK0885004T3 (da) | 2002-08-19 |
| ES2174220T3 (es) | 2002-11-01 |
| KR100352358B1 (ko) | 2003-03-10 |
| DE69712325T2 (de) | 2002-11-28 |
| AU1878297A (en) | 1997-09-22 |
| JP2000507542A (ja) | 2000-06-20 |
| BR9708171A (pt) | 1999-07-27 |
| US5962472A (en) | 1999-10-05 |
| AU717140B2 (en) | 2000-03-16 |
| EP0885004B1 (en) | 2002-05-02 |
| DE69712325D1 (de) | 2002-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9812046A (pt) | Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto | |
| EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
| MY138352A (en) | Benzothiazole derivatives | |
| UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
| HUP0001192A2 (hu) | Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására | |
| CL2003002756A1 (es) | Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia. | |
| ES2141137T3 (es) | Agentes terapeuticos para la enfermedad de parkinson. | |
| ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
| DE60001586D1 (de) | Diphenyl-piperidin derivate | |
| WO1999024022A3 (en) | Isoquinoline derivatives for treating disorders associated with 5ht7 receptors | |
| DK0779284T3 (da) | Hidtil ukendte 2-naphtanamidderivater og terapeutiske anvendelser heraf som agonister af D3-receptorer | |
| HUP0104963A2 (hu) | Bőrbetegségek kezelésére szolgáló készítmények | |
| PT885004E (pt) | Utilizacao de derivados de 4-fenil-3,6-di-hidro-2h-piridilo como bloqueadores dos subtipos dos receptores nmda | |
| ATE277893T1 (de) | N-(2-phenyl-4-amino-butyl)-1-naphthamide als neurokinin-1 rezeptorantagonisten | |
| MY111474A (en) | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders. | |
| PT99864A (pt) | Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato | |
| TR200002831A2 (tr) | Kinolin-4-İl türevleri I | |
| NO983510L (no) | Kondenserte 2,3-benzodiazepinderivater og deres anvendelse som AMPA-reseptorinhibitorer | |
| SE9401087D0 (sv) | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | |
| SE9900190D0 (sv) | New compounds | |
| FR2618435B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique | |
| DK0850062T3 (da) | Anvendelse af halofuginon til fremstilling af et medikament til svækkelse af neovaskularisering og til behandling af maligne tumorer hos mennesker | |
| BR9708922A (pt) | Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso | |
| NO992316L (no) | Benzensulfonamidderivater og legemidler inneholdende disse | |
| TR199900013T2 (xx) | Yeni bile�ikler. |